flanders.bio is a dynamic, member driven organisation with currently more than 350 members from Belgium and abroad. We help our members to create value by organising Networking and Training Activities, supporting Internationalisation, providing Services and building Expertise. flanders.bio and its members want to be the proud advocates of a reputable global-impact ecosystem in life sciences.
News from flanders.bio and its members
Mithra announces new agreement with GSP for development of an additional injectable
Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces that it has entered into a new agreement with Generic Speciality Pharma (GSP) for the development and supply of a sterile hormonal injectable product at Mithra CDMO1. Headquartered in Dublin, GSP is part of the Alter Pharma group, a Belgian pharmaceutical conglomerate focused on the development and manufacturing of niche generics, complex generics and high added value products.
MouSensor is now Yesse Technologies
MouSensor is very pleased to announce our official rebrand of the company from MouSensor to Yesse Technologies (strongly pronounced as Yes!).
VIB: Permit for CRISPR maize field trial that aims to measure climate stress
On April 12, 2019 VIB has been granted a permit for its field trial with maize plants that contain small surgical CRISPR-induced heritable changes. Obtaining this permit allows VIB to continue the field work that was already initiated in 2017
Galapagos creates new warrant plans
Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its board of directors created 2,070,000 warrants under new warrant plans for the benefit of the employees, directors, and a consultant of the company and its subsidiaries.